Question 1

What are the potential side effects of cetuximab and bevacizumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age clinical trial (NCT05956821). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age clinical trial (NCT05956821). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like, and how often will I need to come in for visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age clinical trial (NCT05956821). Contact the study team or your healthcare provider for specific answers.

Question 4

What are the criteria for being eligible for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age clinical trial (NCT05956821). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age clinical trial (NCT05956821). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects during the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age clinical trial (NCT05956821). Contact the study team or your healthcare provider for specific answers.

What this study is about